Baofeng Hu

1.4k citations
25 papers · 956 indexed · h-index 16
Topics
Antimicrobial Resistance in Staphylococcus (8 papers)Antibiotic Resistance in Bacteria (4 papers)Inflammasome and immune disorders (4 papers)

In The Last Decade

Baofeng Hu

25 papers receiving 947 citations

Peers

Baofeng Hu
Comparison fields: 5 of 91
  • Molecular Biology 578
  • Immunology 285
  • Infectious Diseases 191
  • Genetics 116
  • Epidemiology 114
Replace Genyan Liu with:
Genyan Liu China
Hernán F. Peñaloza Chile
Hafid Soualhine Canada
Alessandra Mattos Saliba Brazil
Yukiko Nagano Japan
Sina Mohammadi United States
Julia Sanchez‐Garrido United Kingdom
Cristina Cigana Italy
Jari Intra Italy
Abby L. Geis United States
Baofeng Hu relative to Genyan Liu China Genyan Liu's profile →
Citations per field
00.5×
Genyan Liu · 1×
Citations per year

Countries citing papers authored by Baofeng Hu

Since Specialization
Citations

This map shows the geographic impact of Baofeng Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baofeng Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baofeng Hu more than expected).

Fields of papers citing papers by Baofeng Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Baofeng Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baofeng Hu. The network helps show where Baofeng Hu may publish in the future.

Co-authorship network of co-authors of Baofeng Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Baofeng Hu. A scholar is included among the top collaborators of Baofeng Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Baofeng Hu. Baofeng Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 6
3 94
4 2
5 3
6 16
7 67
8 9
9 93
10 222
11 12
12 18
13 19
14 31
15 71
16 8
17 14
18 23
19 62
20 29

About Baofeng Hu

Baofeng Hu is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Endocrinology, having authored 25 papers that have together received 956 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (8 papers), Antibiotic Resistance in Bacteria (4 papers) and Inflammasome and immune disorders (4 papers). The work is most often cited by research in Endocrinology (108 citations), Molecular Medicine (84 citations) and Immunology (285 citations). Baofeng Hu has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include Irving Nachamkin, Igor E. Brodsky, Meghan A. Wynosky-Dolfi, Naomi H. Philip, Ebbing Lautenbach, Pam Tolomeo, Erin E. Zwack, Christopher P. Dillon, Douglas R. Green and Paul H. Edelstein. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026